Jared N. Schwartz, M.D., Ph.D., Joins Aperio as Chief Medical Officer

Global Digital Pathology Leader Strengthens Clinical Focus with Addition of
Renowned Pathologist
VISTA, Calif.--(Business Wire)--
Aperio Technologies, Inc., (Aperio), a global leader in digital pathology for
the healthcare and life sciences industry, has appointed Jared N. Schwartz,
M.D., Ph.D., as its Chief Medical Officer (CMO).

Dr. Schwartz, former president of the College of American Pathologists, is a
leading advocate for improving patient care using technologies such as digital
pathology. In his new role as Aperio`s CMO, Dr. Schwartz will continue to
interact with the pathology community-including key opinion leaders,
professional medical and advocacy societies, and medical directors of major
clinical and regulatory organizations-about the benefits of digital pathology.
In addition, he will develop and drive execution of Aperio`s clinical strategy
in all medical and clinical efforts for scientific publications, product
investigations and regulatory submissions. Dr. Schwartz will also provide
medical input, perspective and vision to the executive management team and
provide senior-level leadership for related functions.

"We are honored that a pathologist with Dr. Schwartz`s accomplishments is
joining the market leader in digital pathology," said Dirk G. Soenksen, CEO of
Aperio. "We believe the clinical market is poised for rapid growth, and look
forward to working together with Dr. Schwartz to develop and execute strategies
for improving laboratory workflow and to identify opportunities for new image
analysis tools. The medical leadership that Dr. Schwartz brings to Aperio will
allow us to be more responsive to the needs of our growing installed base of
clinical customers."

Dr. Jared Schwartz commented, "The digital pathology market-fueled by demand for
increased accuracy and efficiency of pathology services-is at a very exciting
stage. The potential benefits of digital pathology to pathologists, clinicians
and patients are compelling. In my new role as Aperio`s CMO, I see an
opportunity to combine my passion for education and technology with my
long-standing focus on improving patient care."

Dr. Schwartz brings 30 years of pathology expertise to his new role as CMO, most
recently serving as President of the College of American Pathologists, and
Director of Pathology and Laboratory Medicine at Presbyterian Healthcare in
Charlotte, North Carolina. Board certified in anatomic and clinical pathology
with subspecialty boards in medical microbiology and cytopathology, he is a
graduate of Duke University Medical School, where he completed his residency and
fellowship training, and served as chief resident. He was appointed to the
Clinical Laboratory Improvement Advisory Committee by HHS and is a current
member. He was a co-chair and author of the ASCO/CAP Guidelines on HER2, which
was published in the January 2007 editions of the Journal of Clinical Oncology
and Archives of Pathology and Laboratory Medicine. He is currently a co-chair
and one of the co-authors of the ASCO/CAP Guidelines on ER/PR, which will be
published in both journals in 2010.

Aperio currently has an installed base of more than 500 systems in 34 countries,
including more than two-thirds of the top 15 rated U.S. hospitals, leading
academic medical centers and reference laboratories, and 14 of the top 15
pharmaceutical companies.

About Aperio

Aperio is the leading provider of digital pathology solutions in hospital and
reference labs, academic medical centers, and biopharma institutions across the
world. Today, our affordable and complete product portfolio is proven to lower
costs, increase efficiencies, and enhance workflow in labs everywhere. Our
comprehensive product line features our ScanScope scanners, Spectrum image
management (PACS) software, SecondSlide slide sharing service for pathology, and
image analysis tools and services. Aperio`s products are FDA cleared for
specific clinical applications, and are intended for research and education use
for other applications. For clearance updates and more information please visit
www.aperio.com.

Aperio
Jessica Witkowski, 760-539-1162
Director, Marketing Communications
jessica@aperio.com
or
Myla Wagner Public Relations
Myla Wagner, 925-736-7515
myla@mylawagnerpr.com

Copyright Business Wire 2009